Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus

BACKGROUND AND OBJECTIVE: Obesity is globally recognized as an important clinical problem and sodium-glucose co-transporter 2 (SGLT2) inhibitors are considered a suitable therapy for obese patients with type 2 diabetes mellitus (T2DM). We examined the clinical factors associated with initial decreas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurinami, Noboru, Sugiyama, Seigo, Nishimura, Hiroyuki, Morita, Ayami, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762773/
https://www.ncbi.nlm.nih.gov/pubmed/29098566
http://dx.doi.org/10.1007/s40261-017-0580-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762773/
https://www.ncbi.nlm.nih.gov/pubmed/29098566
http://dx.doi.org/10.1007/s40261-017-0580-6

Ejemplares similares